Coronary artery bypass grafting after aprotinin: Are we doing better?

Journal of Thoracic and Cardiovascular Surgery

Volumn 145, Issue 1, 2013, Pages 243-248

  Beckerman, Ziv ^a   Shopen, Yoni ^a   Alon, Hagar ^a   Cohen, Oved ^a   Nir, Rony Reuven ^a   Adler, Zvi ^a   Bolotin, Gil ^a  

^a Rambam Health Care Campus ^*  (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; TRANEXAMIC ACID; TROPONIN;

ACUTE KIDNEY FAILURE; ADULT; AORTA CLAMPING; ARTICLE; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; CARDIAC PATIENT; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; DRUG SAFETY; ELECTIVE SURGERY; FEMALE; HEMATOCRIT; HUMAN; INTRACARDIAC THROMBOSIS; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; THROMBOCYTE COUNT;

AGED; ANTIFIBRINOLYTIC AGENTS; APROTININ; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PATIENT SAFETY; PATIENT SELECTION; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 84871244547     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2012.09.032     Document Type: Article

References (29)

1. D.A. Fergusson, P.C. Hébert, C.D. Mazer, S. Fremes, C. MacAdams, and J.M. Murkin A comparison of aprotinin and lysine analogues in high-risk cardiac surgery N Engl J Med 358 2008 2319 2331 (Pubitemid 351749156)
2. D.T. Mangano, Y. Miao, A. Vuylsteke, I.C. Tudor, D. Filipescu, and A. Hoeft Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery JAMA 297 2007 471 479
3. M. Sperzel, and J. Huetter Evaluation of aprotinin and tranexamic acid in different in vitro and in vivo models of fibrinolysis, coagulation and thrombus formation J Thromb Haemost 5 2007 2113 2118 (Pubitemid 47450031)
4. A. Sedrakyan, T. Treasure, and J.A. Elefteriades Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials J Thorac Cardiovasc Surg 128 2004 442 448 (Pubitemid 39194703)
5. N.P. Dowd, J.M. Karski, D.C. Cheng, J.A. Carroll, Y. Lin, and R.L. James Pharmacokinetics of tranexamic acid during cardiopulmonary bypass Anesthesiology 97 2002 390 399 (Pubitemid 34847752)
6. A.F. Later, J.J. Maas, F.H. Engbers, M.I. Versteegh, E.F. Bruggemans, and R.A. Dion Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial Eur J Cardiothorac Surg 36 2009 322 329
7. V. Casati, D. Guzzon, M. Oppizzi, M. Cossolini, G. Torri, and G. Calori Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery Ann Thorac Surg 68 1999 2252 2256
8. A. Penta de Peppo, M.D. Pierri, A. Scafuri, R. De Paulis, G. Colantuono, and E. Caprara Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery: prospective trial of 3 antifibrinolytic drugs Tex Heart Inst J 22 1995 231 236
9. F. Bernet, T. Carrel, G. Marbet, K. Skarvan, and P. Stulz Reduction of blood loss and transfusion requirements after coronary artery bypass grafting: similar efficacy of tranexamic acid and aprotinin in aspirin-treated patients J Card Surg 14 1999 92 97 (Pubitemid 30117818)
10. B. Blauhut, W. Harringer, P. Bettelheim, J.E. Doran, P. Spath, and P. Lundsgaard-Hansen Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass J Thorac Cardiovasc Surg 108 1994 1083 1091 (Pubitemid 24379862)
11. F. Boughenou, S. Madi-Jebara, S. Massonnet-Castel, L. Benmosbah, A. Carpentier, and M.T. Cousin Fibrinolytic inhibitors and prevention of bleeding in cardiac valve surgery: comparison of tranexamic acid and high dose aprotinin Arch Mal Coeur Vaiss 88 1995 363 370
12. V. Casati, D. Guzzon, M. Oppizzi, F. Bellotti, A. Franco, and C. Gerli Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions J Thorac Cardiovasc Surg 120 2000 520 527
13. J.J. Corbeau, J.P. Monrigal, J.P. Jacob, C. Cottineau, X. Moreau, and J.G. Bukowski Comparison of effects of aprotinin and tranexamic acid on blood loss in heart surgery Ann Fr Anesth Reanim 14 1995 154 161
14. P. Diprose, M.J. Herbertson, D. O'Shaughnessy, C.D. Deakin, and R.S. Gill Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage Br J Anaesth 94 2005 271 278 (Pubitemid 40352845)
15. K. Hekmat, T. Zimmermann, S. Kampe, S.M. Kasper, H.J. Weber, and H.J. Geissler Impact of tranexamic acid vs aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial Curr Med Res Opin 20 2004 121 126 (Pubitemid 38063464)
16. C. Isetta, T.K. Gunness, C. Samat, G. Paolini, D. Lugrin, and B. Sanchez Antifibrinolytic treatment and homologous transfusion in cardiac surgery Eur Heart J 14 1993 224
17. W.R. Jamieson, P.J. Dryden, J.P. O'Connor, H. Sadeghi, D.M. Ansley, and P.M. Merrick Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery Circulation 96 9 Suppl 1997 II-96-100; discussion, II-100-1
18. A. Menichetti, L. Tritapepe, G. Ruvolo, G. Speziale, A. Cogliati, and G.C. Di Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid J Cardiovasc Surg (Torino) 37 1996 401 407 (Pubitemid 26254262)
19. P.D. Mongan, R.S. Brown, and B.K. Thwaites Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization Anesth Analg 87 1998 258 265 (Pubitemid 28369074)
20. G.A. Nuttall, W.C. Oliver, M.H. Ereth, P.J. Santrach, S.C. Bryant, and T.A. Orszulak Comparison of blood-conservation strategies in cardiac surgery patients at high risk for bleeding Anesthesiology 92 2000 674 682 (Pubitemid 30130169)
21. B.I. Wong, R.F. McLean, S.E. Fremes, K.A. Deemar, E.M. Harrington, and G.T. Christakis Aprotinin and tranexamic acid for high transfusion risk cardiac surgery Ann Thorac Surg 69 2000 808 816 (Pubitemid 30184701)
22. X. Wang, Z. Zheng, H. Ao, S. Zhang, Y. Wang, and H. Zhang Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery Ann Thorac Surg 89 2010 1489 1495
23. J.H.I.V. Holmes, M.F. Jones, R.P. Anderson, K.D. Knopes, S.W. Guyton, and R.A. Hall The use of micro-dose aprotinin with continuous infusion in coronary artery bypass surgery J Cardiovasc Surg (Torino) 40 1999 621 626
24. M. Kluth, J.U. Lueth, A. Zittermann, M. Lanzenstiel, R. Koerfer, and K. Inoue Safety of low-dose aprotinin in coronary artery bypass graft surgery: a single-centre investigation in 2,436 patients in Germany Drug Saf 31 2008 617 626 (Pubitemid 351861954)
25. M.M. Maddali, M. Das, and R. Kausalya Efficacy of minimal dose aprotinin in open heart procedures Ann Card Anaesth 2 1999 10 14
26. M. Sander, C.D. Spies, V. Martiny, C. Rosenthal, K.D. Wernecke, and C. von Heymann Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis Crit Care 14 2010 R148
27. W. Dietrich, M. Spannagl, J. Boehm, K. Hauner, S. Braun, and T. Schuster Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin Anesth Analg 107 2008 1469 1478
28. M.R. Terrell, J.M. Walenga, M.J. Koza, and R. Pifarre Efficacy of aprotinin with various anticoagulant agents in cardiopulmonary bypass Ann Thorac Surg 62 1996 506 511 (Pubitemid 26259696)
29. S. Lockyer, and J. Kambayashi Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis J Cardiovasc Pharmacol 33 1999 718 725 (Pubitemid 29196709)